Trial Profile
Imatinib in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 30 Aug 2016
Price :
$35
*
At a glance
- Drugs Imatinib (Primary)
- Indications Precursor cell lymphoblastic leukaemia-lymphoma
- Focus Therapeutic Use
- 30 Aug 2016 New trial record